| Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells A Gonzalez-Pujana, KH Vining, DKY Zhang, E Santos-Vizcaino, M Igartua, ... Biomaterials 257, 120266, 2020 | 51 | 2020 |
| Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: latest trends in isolation, content optimization and delivery avenues E Munoz-Perez, A Gonzalez-Pujana, M Igartua, E Santos-Vizcaino, ... Pharmaceutics 13 (11), 1802, 2021 | 46 | 2021 |
| Alginate microcapsules for drug delivery A Gonzalez-Pujana, G Orive, JL Pedraz, E Santos-Vizcaino, ... Alginates and their biomedical applications, 67-100, 2018 | 28 | 2018 |
| Cell microencapsulation technology: Current vision of its therapeutic potential through the administration routes A Gonzalez-Pujana, E Santos, G Orive, JL Pedraz, RM Hernandez Journal of Drug Delivery Science and Technology 42, 49-62, 2017 | 28 | 2017 |
| Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges A Gonzalez-Pujana, M Igartua, E Santos-Vizcaino, RM Hernandez Expert opinion on drug delivery 17 (2), 189-200, 2020 | 27 | 2020 |
| Extracellular matrix protein microarray-based biosensor with single cell resolution: Integrin profiling and characterization of cell-biomaterial interactions A Gonzalez-Pujana, E Santos-Vizcaino, M Garcia-Hernando, ... Sensors and Actuators B: Chemical 299, 126954, 2019 | 18 | 2019 |
| The role of osmolarity adjusting agents in the regulation of encapsulated cell behavior to provide a safer and more predictable delivery of therapeutics A Gonzalez-Pujana, A Rementeria, FJ Blanco, M Igartua, JL Pedraz, ... Drug delivery 24 (1), 1654-1666, 2017 | 15 | 2017 |
| Clinical progress in MSC-based therapies for the management of severe COVID-19 M Rossello-Gelabert, A Gonzalez-Pujana, M Igartua, E Santos-Vizcaino, ... Cytokine & Growth Factor Reviews 68, 25-36, 2022 | 11 | 2022 |
| Human hair follicle-derived mesenchymal stromal cells from the lower dermal sheath as a competitive alternative for immunomodulation B Hernaez-Estrada, A Gonzalez-Pujana, A Cuevas, A Izeta, KL Spiller, ... Biomedicines 10 (2), 253, 2022 | 10 | 2022 |
| Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases A Ceruso, A Gonzalez-Pujana, M Igartua, E Santos-Vizcaino, ... Drug delivery and translational research 11, 498-514, 2021 | 8 | 2021 |
| Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation A Gonzalez-Pujana, A Beloqui, JJ Aguirre, M Igartua, E Santos-Vizcaino, ... European Journal of Pharmaceutics and Biopharmaceutics 172, 31-40, 2022 | 6 | 2022 |
| Monitoring implantable immunoisolation devices with intrinsic fluorescence of genipin E Santos‐Vizcaino, H Haley, A Gonzalez‐Pujana, G Orive, ... Journal of biophotonics 12 (4), e201800170, 2019 | 5 | 2019 |
| Hybrid 3D Printed and electrospun multi-scale hierarchical polycaprolactone scaffolds to induce bone differentiation A Gonzalez-Pujana, T Carranza, E Santos-Vizcaino, M Igartua, ... Pharmaceutics 14 (12), 2843, 2022 | 4 | 2022 |
| 3D encapsulation and inflammatory licensing of mesenchymal stromal cells alter the expression of common reference genes used in real-time RT-qPCR A Gonzalez-Pujana, I De Lázaro, KH Vining, E Santos-Vizcaino, M Igartua, ... Biomaterials science 8 (23), 6741-6753, 2020 | 3 | 2020 |
| Hybrid 3D Printed and Electrospun Multi-Scale Hierarchical Polycaprolactone Scaffolds to Induce Bone Differentiation. Pharmaceutics 2022, 14, 2843 A Gonzalez-Pujana, T Carranza, E Santos-Vizcaino, M Igartua, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Bioinspired three-dimensional multifunctional systems to enhance the therapeutic potential of mesenchymal stromal cells A González Pujana | | 2019 |
